Two Phase, Repeated Crossover Study With Dose Escalation on Delta(9)-Tetrahydrocannabinol (Delta-THC) in Behavioral Disturbances in Dementia.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Dronabinol (Primary)
- Indications Alzheimer's disease; Vascular dementia
- Focus Therapeutic Use
- 21 Jan 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 29 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Mar 2012 Additional lead trial centre identified as reported by European Clinical Trials Database record.